Bioequivalence Explained: FDA Requirements to Prove Generic Equivalence
Learn how the FDA proves generic drugs are equivalent to brand names. We explain bioequivalence standards, the 80-125% rule, and the science behind ANDA approvals.
Tag: bioequivalence
Pharmacist Concerns About Generic Substitution: Real-World Perspectives and Solutions
Explore real-world pharmacist concerns about generic substitution, including patient resistance, NTI drug risks, and biosimilar complexities. Learn how to improve acceptance and safety.
Clinical Outcomes Data: What Studies Tell Providers About Generics
Clinical outcomes data shows generic drugs deliver the same therapeutic results as brand-name drugs, with real-world evidence confirming equivalent safety and effectiveness across nearly all drug classes.
Dissolution Testing: How FDA Ensures Generic Drug Quality
The FDA uses dissolution testing to ensure generic drugs release their active ingredients at the same rate as brand-name versions. This scientific method replaces costly human trials while guaranteeing therapeutic equivalence.
Bioequivalence for Inhalers, Patches, and Injections: What Generic Drug Developers Need to Know
Bioequivalence for inhalers, patches, and injections requires more than just matching drug levels in blood. Learn how particle size, delivery devices, and release rates determine if a generic works as well as the brand.
Switching Between Generic Medications: What You Need to Know
Switching between generic medications is common and often saves money, but for drugs like thyroid hormone or blood thinners, it can be risky. Learn how to spot changes, protect yourself, and when to push back.
Population Pharmacokinetics: How Data Proves Drug Equivalence Beyond Traditional Bioequivalence
Population pharmacokinetics uses real-world patient data to prove drug equivalence where traditional methods fail - especially in children, elderly, and those with organ impairment. Learn how it's changing regulatory standards.